Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?

Neurosci Lett. 2000 Apr 28;284(3):187-9. doi: 10.1016/s0304-3940(00)01009-0.

Abstract

Little is known about the metabolic process of tau and tau-derived substances. Alz-50- and tau 2-immunoreactivities in intracellular granules of neurons were observed in regions surrounding infarcted foci in the human cerebral cortex. Ultrastructurally, these granules in the fresh infarcted region exhibited primary lysosome-like structures, while those in old infarctions were lipofuscin. These findings indicate that tau is metabolized within lysosomes in neurons damaged by ischemic injury in human cortical penumbra. Alz-50-positive granules were more prominent in fresh infarction than in old infarction. After undergoing degradation and modification, altered tau might remain, at least partially, in secondary lysosomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antigens / analysis*
  • Antigens / immunology
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • Cerebral Cortex / metabolism*
  • Cerebral Cortex / pathology
  • Cerebral Cortex / ultrastructure
  • Cerebral Infarction / metabolism*
  • Cerebral Infarction / pathology
  • Cytoplasmic Granules / chemistry
  • Cytoplasmic Granules / metabolism
  • Cytoplasmic Granules / ultrastructure
  • Humans
  • Immunohistochemistry
  • Lipofuscin / analysis
  • Lysosomes / chemistry
  • Lysosomes / metabolism*
  • Lysosomes / ultrastructure
  • Microscopy, Immunoelectron
  • Neurons / metabolism*
  • Neurons / pathology
  • Neurons / ultrastructure
  • Time Factors
  • tau Proteins / chemistry
  • tau Proteins / immunology
  • tau Proteins / metabolism*

Substances

  • Alzheimer's disease antigen
  • Antigens
  • Lipofuscin
  • tau Proteins